CTLT
$CTLT
Catalent, Inc.
Contract development and manufacturing organization providing drug delivery technologies.
HealthcareAnalyst Rating
Hold
0 Buy / 11 Hold / 3 Sell
Subscribers
0
Tracking this ticker
Next Report
Sun, Mar 29
Weekly updates
Latest Report
CTLT Catalent: Valuation, Risks, and Outlook
CTLT displays a strong balance sheet and low beta but negative earnings and a weak ROE. Analysts are largely on the sidelines, leaving limited near-term upside while long-term catalysts exist.
Mar 16, 2026